The QSAR analysis of tricyclic non-nucleoside inhibitors of HIV-1 reverse transcriptase

Acta Poloniae Pharmaceutica - Drug Research

Volumn 60, Issue 1, 2003, Pages 3-13

  Brzezińska, Elzbieta ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Non nucleoside inhibitors HIV 1 RT; QSAR analysis

Indexed keywords

BENZODIAZEPINE DERIVATIVE; DIAZEPINE DERIVATIVE; DIBENZO[B,F][1,5]OXAZOCINE 12 ONE; DIBENZOXAZEPINE DERIVATIVE; LIGNAN DERIVATIVE; NEVIRAPINE; OXAZEPINE DERIVATIVE; OXAZOCINE DERIVATIVE; PYRIDOBENZO[B,F][1,5]OXAZOCINE 5 ONE; RNA DIRECTED DNA POLYMERASE; RNA DIRECTED DNA POLYMERASE INHIBITOR; TANNIN DERIVATIVE; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CHEMICAL PARAMETERS; COMPUTER PROGRAM; CONTROLLED STUDY; CORRELATION FUNCTION; DATA ANALYSIS; ENZYME INHIBITION; HUMAN IMMUNODEFICIENCY VIRUS 1; IC 50; MOLECULAR MODEL; NONHUMAN; PHYSICAL PARAMETERS; QUANTITATIVE STRUCTURE ACTIVITY RELATION; REGRESSION ANALYSIS; THREE DIMENSIONAL IMAGING;

ALGORITHMS; CHEMISTRY, PHYSICAL; DRUG DESIGN; HIV-1 REVERSE TRANSCRIPTASE; HUMANS; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; REVERSE TRANSCRIPTASE INHIBITORS;

EID: 0038287947     PISSN: 00016837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Campagni G., Ramunno A., Maga G., Nacci V., Fattorusso C., Catalanotti B., Morelli E., Novellino E.: Curr. Pharm. Des. 8, 615 (2002).
2. Gussio R., Pattabirama N., Zaharevitz D., Kellog G.: J. Med. Chem. 39, 1645 (1996).
3. Schafer W., Friebe W.-G., Leinert H., Mertens A., Poll T,, der Saal W., Zilch H.: J. Med. Chem. 36, 726 (1993).
4. Chen Liu K., Lee S.S., Chang Ch.W., Liu Ch.L., Lin J.Y., Hsu F.L., Ren S., Lien E.: Med. Chem. Res. 7, 168 (1997).
5. Rizzo R., Tirado-Rives J., Jorgensen W.: J. Med. Chem. 44, 145 (2001).
6. Hannongbua S., Prasithichokekul S., Pungpo P.: J. Comput. Aided Mol. Des. 15, 997 (2001).
7. Mestres J., Rohrer D., Maggiora G.: J. Comput. Aided Mol. Des. 13, 79 (1999).
8. Nowak D., Glinka R., Pietras T., Cieśliński M., Mazerant P., Idowski P., Leder M., Sidorkiewicz M.: Il Farmaco 52, 751 (1997).
9. Klunder J., Hargrave K., West M.A., Cullen E., Pal K., Behnke M., Kapadia S., McNeil D., Wu J., Chow G., Adams J.: J. Med. Chem. 35, 1887 (1992).
10. Hargrave K., Proudfoot K., Grozinger E., Cullen E., Kapadia S., Patel U., Skiles J., McNeil D., Rose J., Chow G., Skoog M., Wu J., Schmidt G., Engel W., Eberlein W., Saboe T., Campbell S., Rosenthal A., Adams J.: J. Med. Chem. 34, 2231 (1991).
11. Kelly T., McNeil D., Rose J., David E., Cheng-Kon Shihgrob P.: J. Med. Chem. 40, 2430 (1997).
12. Brzezińska E., Glinka R.: Acta Polon. Pharm. Drug Res. 59 (5), 379 (2002).
13. Hannongbua S., Prasithichokekul S., Pungpo P.: J. Comput. Aided Mol. Des. 15, 997 (2001).
14. Chimirri A., Grasso S., Monforte P., Rao A., Zappala M., Monforte A., Pannecouque C., Witvrouw M., Balzarini J., De Clercq E.: Antivir. Chem. Chemother. 10, 211 (1999).
15. Kellogg G., Semus S., Abraham D.: J. Computer Aided Mol. Design. 5, 545 (1991).
16. Meng E., Kuntz I., Abraham D., Kellogg G.: J. Comput. Aided Mol. Design. 8, 299 (1994).
17. Gussio R., Pattabiraman N., Kellogg G., Zaharevitz D.: Methods 14, 255 (1998).
18. Zaharevitz D. Gussio R., Wiegand A., Jalluri R., Pattabirman N., Kellogg G., Pallansch L., Yang S., Buckheit, Jr. R.: Med. Chem. Res. 9, 551 (1999).